Hebei Province Releases June 2026 List of 11 Chemical Medicines Eligible for Provincial Procurement Platform Listing

(Source: Medical and Health News)

Yesterday,Hebei Provincial Medical Drug and Device Centralized Procurement Center released《Notice on the Public Listing of Certain Eligible Drugs》, and announcedTable of Chemical Drugs Meeting Online Listing Conditions、Table of Chemical Drugs Not Meeting the Conditions for Online Listing, which has attracted widespread attention in the industry.

The "Notice" points out that, in accordance with the regulations of Hebei Province requiring the listing price of chemical drugs to be no higher than the lowest price within the same group, the following is hereby announced:Public Notice of Drugs Eligible for Online Listing in June。Public Notice Period: June 24, 2026 – June 28, 2026。

Based on the review,In June, a total of 11 chemical drugs met the criteria for online listing., includingAcetylmiocamycin for Suspension, Atenolol Tablets, Acyclovir Eye Drops, Dexamethasone Sodium Phosphate Eye Drops, Compound Gentian and Sodium Bicarbonate Tablets, Soda Lime, Hydrocortisone Tablets, Arginine Hydrochloride Injection, Lidocaine Hydrochloride Mucilage (I), Defibrase for Injection, Zolmitriptan Tablets。

Among these 11 drugs, involving10 Pharmaceutical Manufacturing Enterprises, Huaqing Pharmaceutical Co.,Ltd. XinXiang had the most products, with a total of 2. Among them,The product with the lowest proposed online listing price isAcyclovir Eye Drops, the price is4.65 yuan; the product with the highest proposed listing price isDefibrase for Injection, priced at245 yuan。

Meanwhile,In June, a total of 117 chemical drugs did not meet the criteria for online listing., includingAlprazolam Tablets, Paracetamol Pseudoephedrine and Chlorphenamine Oral Solution, Ribavirin Injection, Erythromycin Ointment, etc.,Reasons for non-compliance are varied, with the top three being: exceeding the lowest price in the same group, centralized procurement under the same generic name, and exclusivity, particularlyMedicines priced lower than the lowest price in their peer group account for more than 58.97%.